Literature DB >> 29909468

A high incidence and coexistence of multiresistance genes cfr and optrA among linezolid-resistant enterococci isolated from a teaching hospital in Wenzhou, China.

Yizhi Zhang1, Guofeng Dong2, Jiahui Li1, Lijiang Chen1, Haiyang Liu1, Wenzi Bi2, Hong Lu1, Tieli Zhou3.   

Abstract

Linezolid is considered as a last-resort antimicrobial agent, the resistance of which is of great concern. The aim of this study was to investigate the mechanisms and transferability of linezolid resistance and molecular epidemiology of linezolid-resistant enterococcal isolates in Wenzhou, China. A collection of 1623 enterococcal strains, including 789 Enterococcus faecalis and 834 Enterococcus faecium, were isolated from our hospital during 2011-2016. Antimicrobial susceptibility testing and clinical data analysis were performed. Molecular mechanisms of linezolid resistance, including the existence of resistance genes cfr and optrA, as well as the mutations in 23S rRNA and ribosomal proteins L3, L4, and L22, were investigated by PCR and sequencing. Conjugation experiments were conducted, and epidemiological characteristics were analyzed by PFGE and MLST. In our study, 31 (3.93%) E. faecalis and 2 (0.24%) E. faecium exhibited resistance to linezolid. Risk factors correlated with linezolid-resistant enterococcal infections included gastrointestinal surgery hospitalization, urogenital disorders, tumor, diabetes, and polymicrobial infections. Among these isolates, 6 (18.18%) harbored cfr, 9 (27.27%) harbored optrA, and 18 (54.55%) co-harbored cfr and optrA. However, mutational mechanisms were not found in this study. Conjugation experiments demonstrated the transferability of cfr and optrA between Gram-positive and Gram-negative bacteria. The clone of these isolates was diverse and scattered. It is noteworthy that cfr and optrA were the main mechanisms of linezolid resistance in this study, posing a potential risk of spread of linezolid resistance. Strikingly, it reported firstly that the two transferable resistance genes cfr and optrA coexisted in the same E. faecalis isolates.

Entities:  

Keywords:  Enterococci; Linezolid resistance; Transferability; cfr; optrA

Mesh:

Substances:

Year:  2018        PMID: 29909468     DOI: 10.1007/s10096-018-3269-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013.

Authors:  Rodrigo E Mendes; Patricia A Hogan; Jennifer M Streit; Ronald N Jones; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Low fitness cost of the multidrug resistance gene cfr.

Authors:  Jacqueline M LaMarre; Jeffrey B Locke; Karen J Shaw; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

3.  Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada.

Authors:  Samir N Patel; Nader Memari; Dea Shahinas; Baldwin Toye; Frances B Jamieson; David J Farrell
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-02       Impact factor: 2.803

4.  Resistance mechanisms of linezolid-nonsusceptible enterococci in Korea: low rate of 23S rRNA mutations in Enterococcus faecium.

Authors:  Sae-Mi Lee; Hee Jae Huh; Dong Joon Song; Hyang Jin Shim; Kyung Sun Park; Cheol-In Kang; Chang-Seok Ki; Nam Yong Lee
Journal:  J Med Microbiol       Date:  2017-11-07       Impact factor: 2.472

5.  Polyphyletic emergence of linezolid-resistant staphylococci in the United States.

Authors:  Agnes Wong; Shilpa P Reddy; Davida S Smyth; Maria E Aguero-Rosenfeld; George Sakoulas; D Ashley Robinson
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

6.  Prevalence and molecular characterization of tetracycline resistance in Enterococcus isolates from food.

Authors:  Geert Huys; Klaas D'Haene; Jean-Marc Collard; Jean Swings
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

7.  Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.

Authors:  Lalitagauri M Deshpande; Deborah S Ashcraft; Heather P Kahn; George Pankey; Ronald N Jones; David J Farrell; Rodrigo E Mendes
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

8.  Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).

Authors:  Robert K Flamm; Rodrigo E Mendes; Patricia A Hogan; Jennifer M Streit; James E Ross; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

9.  Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance.

Authors:  I Gawryszewska; D Żabicka; W Hryniewicz; E Sadowy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-14       Impact factor: 3.267

10.  Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.

Authors:  Alexandros Lazaris; David C Coleman; Angela M Kearns; Bruno Pichon; Peter M Kinnevey; Megan R Earls; Breida Boyle; Brian O'Connell; Gráinne I Brennan; Anna C Shore
Journal:  J Antimicrob Chemother       Date:  2017-12-01       Impact factor: 5.790

View more
  7 in total

1.  Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant Enterococcus.

Authors:  Yaowen Li; Yu Peng; Na Zhang; Huiping Liu; Jun Mao; Yisong Yan; Shuaishuai Wang; Guang Yang; Yanyan Liu; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2022-08-30       Impact factor: 4.177

2.  In vitro Antibacterial Activity of Isopropoxy Benzene Guanidine Against Multidrug-Resistant Enterococci.

Authors:  Xiufeng Zhang; Dongdong Han; Pengfei Pei; Jie Hao; Yixing Lu; Peng Wan; Xianfeng Peng; Weibiao Lv; Wenguang Xiong; Zhenling Zeng
Journal:  Infect Drug Resist       Date:  2019-12-23       Impact factor: 4.003

3.  Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017.

Authors:  Lin Huang; Rong Zhang; Yanyan Hu; Hongwei Zhou; Junmin Cao; Huoyang Lv; Shi Chen; Shibiao Ding; Gongxiang Chen
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-30       Impact factor: 4.887

4.  Linezolid-Resistant Enterococcus spp. Isolates from Foods of Animal Origin-The Genetic Basis of Acquired Resistance.

Authors:  Urszula Zarzecka; Arkadiusz Józef Zakrzewski; Wioleta Chajęcka-Wierzchowska; Anna Zadernowska
Journal:  Foods       Date:  2022-03-28

5.  Emergence of optrA-Mediated Linezolid-Nonsusceptible Enterococcus faecalis in a Tertiary Care Hospital.

Authors:  Kuenyoul Park; Yun Sil Jeong; Jeonghyun Chang; Heungsup Sung; Mi Na Kim
Journal:  Ann Lab Med       Date:  2020-07       Impact factor: 3.464

6.  Analysis of combined resistance to oxazolidinones and phenicols among bacteria from dogs fed with raw meat/vegetables and the respective food items.

Authors:  Yifan Wu; Run Fan; Yinchao Wang; Lei Lei; Andrea T Feßler; Zheng Wang; Congming Wu; Stefan Schwarz; Yang Wang
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

7.  Coexistence of the Oxazolidinone Resistance-Associated Genes cfr and optrA in Enterococcus faecalis From a Healthy Piglet in Brazil.

Authors:  Lara M Almeida; Anthony Gaca; Paulo M Bispo; François Lebreton; Jose T Saavedra; Rafael A Silva; Irinaldo D Basílio-Júnior; Felipe M Zorzi; Pedro H Filsner; Andrea M Moreno; Michael S Gilmore
Journal:  Front Public Health       Date:  2020-09-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.